Drug-Coated Balloon-Only Strategy for De Novo Coronary Artery Disease: A Meta-analysis of Randomized Clinical Trials
Backgrounds. Many clinical trials have demonstrated the value of drug-coated balloons (DCB) for in-stent restenosis. However, their role in de novo lesions is not well documented. The aim of this study is to evaluate the safety and efficacy of the DCB-only strategy compared to other percutaneous cor...
Saved in:
Main Authors: | Wenyi Zhang, Mingduo Zhang, Jinfan Tian, Min Zhang, Yuan Zhou, Xiantao Song |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Cardiovascular Therapeutics |
Online Access: | http://dx.doi.org/10.1155/2023/3121601 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expanding the Role of Drug-Coated Balloons in Treating De Novo Coronary Artery Disease
by: Anna van Veelen, MD, PhD, et al.
Published: (2025-01-01) -
A Prospective Randomized Trial Comparing 2 Different Paclitaxel-Coated Balloons in De Novo Coronary Artery Disease
by: Eun-Seok Shin, MD, PhD, et al.
Published: (2025-01-01) -
Drug-Coated versus Uncoated Balloon for Side Branch Protection in Coronary Bifurcation Lesions Treated with Provisional Stenting Using Drug-Eluting Stents: A Meta-analysis
by: Zhi-Ming Jiang, et al.
Published: (2022-01-01) -
Peripheral Artery Disease Intervention: Drug-Coated Balloon vs Drug-Eluting Stent, A Long-Term Comparison
by: Nathan Marzlin, et al.
Published: (2022-01-01) -
Stentless Strategy by Drug-Coated Balloon Angioplasty following Directional Coronary Atherectomy for Left Main Bifurcation Lesion
by: Norihiro Kobayashi, et al.
Published: (2021-01-01)